Geffroy-Roisne S, Duval J, Thieulant M L
Laboratoire d'Endocrinologie Moleculaire, Centre National de la Recherche Scientifique, Unité de Recherches Associée, Rennes, France.
Endocrinology. 1992 Sep;131(3):1503-10. doi: 10.1210/endo.131.3.1505480.
The presence of multiple monomeric forms has been described for estrogen receptor (ER) in different target tissues. Using [3H]tamoxifen aziridine ([3H]TA) to covalently label ER and sodium dodecyl sulfate-polyacrylamide gel electrophoresis to analyze labeled products, ER forms were investigated in pituitary cytosol and purified nuclei from male rats. ER forms were also compared in cellular extracts from gonadotrope-enriched populations (GP), prepared using the fast method of centrifugal elutriation, and from lactotrope-somatotrope fractions (LSP), obtained by sequential use of both elutriation and Percoll gradient sedimentation. A major labeled protein of 60,000-65,000 mol wt (M(r)) and a minor species of 50,000-55,000 M(r) were found in the pituitary cytosol and nuclear extracts covalently labeled with [3H]TA. The same results were obtained after ER covalent labeling from cellular extracts or intact dispersed cells. In gonadotrope-enriched cell population (greater than or equal to 50% LH-immunoreactive cells), the 65,000 M(r) species is the single unique ER form; in the LSP (80% PRL- and GH-immunoreactive cells), the major TA-labeled species is the 50,000 M(r) form, while the 65,000 M(r) ER is hardly detectable. Thus, the prevalence of 65,000 M(r) protein in the initial cell population can be explained by the higher number of binding sites per gonadotrope than per lactotrope cell. In conclusion, ER heterogeneity is demonstrated in pituitary cell populations. The source of this heterogeneity could be due to 1) different ER mRNAs according to cell type, or 2) a specific posttranslational processing, such as proteolytic activity within lactotrope cells.
雌激素受体(ER)在不同靶组织中存在多种单体形式。使用[³H]他莫昔芬氮丙啶([³H]TA)对ER进行共价标记,并采用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析标记产物,对雄性大鼠垂体细胞质和纯化细胞核中的ER形式进行了研究。还比较了采用离心淘析快速方法制备的富含促性腺激素细胞群体(GP)以及通过依次使用淘析和Percoll梯度沉降获得的催乳素-生长激素细胞组分(LSP)的细胞提取物中的ER形式。在用[³H]TA共价标记的垂体细胞质和核提取物中发现了一种主要的分子量为60,000 - 65,000道尔顿(M(r))的标记蛋白以及一种分子量为50,000 - 55,000 M(r)的次要蛋白。从细胞提取物或完整分散细胞进行ER共价标记后也得到了相同的结果。在富含促性腺激素细胞群体(≥50% LH免疫反应性细胞)中,65,000 M(r)的蛋白是唯一的ER形式;在LSP(80% PRL和GH免疫反应性细胞)中,主要的TA标记蛋白是50,000 M(r)的形式,而65,000 M(r)的ER几乎检测不到。因此,初始细胞群体中65,000 M(r)蛋白的优势可以通过每个促性腺激素细胞比每个催乳素细胞具有更多的结合位点来解释。总之,垂体细胞群体中存在ER异质性。这种异质性的来源可能是由于1)根据细胞类型不同的ER mRNA,或者2)特定的翻译后加工,例如催乳素细胞内的蛋白水解活性。